These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32794745)

  • 21. Discovery of selective Mcl-1 inhibitors via structure-based design and structure-activity relationship analysis.
    He N; Liu P; Wang Z; Guo Z; Yan X; Chen H; Zhang Z
    Biochem Biophys Res Commun; 2019 May; 512(4):921-926. PubMed ID: 30928099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixed-ligand mononuclear copper(II) complex: crystal structure and anticancer activity.
    Qin XY; Liu YN; Yu QQ; Yang LC; Liu Y; Zhou YH; Liu J
    ChemMedChem; 2014 Aug; 9(8):1665-71. PubMed ID: 24839939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design.
    Friberg A; Vigil D; Zhao B; Daniels RN; Burke JP; Garcia-Barrantes PM; Camper D; Chauder BA; Lee T; Olejniczak ET; Fesik SW
    J Med Chem; 2013 Jan; 56(1):15-30. PubMed ID: 23244564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure elucidation of new μ-oxamido-bridged dicopper(II) complex with in vitro anticancer activity: A combined study from experiment verification and docking calculation on DNA/protein-binding property.
    Zhu L; Zheng K; Li YT; Wu ZY; Yan CW
    J Photochem Photobiol B; 2016 Feb; 155():86-97. PubMed ID: 26773872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3-Substituted-N-(4-hydroxynaphthalen-1-yl)arylsulfonamides as a novel class of selective Mcl-1 inhibitors: structure-based design, synthesis, SAR, and biological evaluation.
    Abulwerdi FA; Liao C; Mady AS; Gavin J; Shen C; Cierpicki T; Stuckey JA; Showalter HD; Nikolovska-Coleska Z
    J Med Chem; 2014 May; 57(10):4111-33. PubMed ID: 24749893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Small-Molecule Inhibitors of the Antiapoptotic Protein Myeloid Cell Leukaemia-1 (Mcl-1).
    Beekman AM; O'Connell MA; Howell LA
    ChemMedChem; 2016 Apr; 11(8):840-4. PubMed ID: 26616140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fragment-Based Design, Synthesis, and Biological Evaluation of 1-Substituted-indole-2-carboxylic Acids as Selective Mcl-1 Inhibitors.
    Wang Z; Xu W; Song T; Guo Z; Liu L; Fan Y; Wang A; Zhang Z
    Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 27911011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of 3,5-Dimethyl-4-Sulfonyl-1
    Zhu PJ; Yu ZZ; Lv YF; Zhao JL; Tong YY; You QD; Jiang ZY
    J Med Chem; 2021 Aug; 64(15):11330-11353. PubMed ID: 34342996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1-Phenyl-1H-indole derivatives as a new class of Bcl-2/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation.
    Xu G; Liu T; Zhou Y; Yang X; Fang H
    Bioorg Med Chem; 2017 Oct; 25(20):5548-5556. PubMed ID: 28866374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mcl-1 Interacts with Akt to Promote Lung Cancer Progression.
    Chen G; Park D; Magis AT; Behera M; Ramalingam SS; Owonikoko TK; Sica GL; Ye K; Zhang C; Chen Z; Curran WJ; Deng X
    Cancer Res; 2019 Dec; 79(24):6126-6138. PubMed ID: 31662324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure of a Myeloid cell leukemia-1 (Mcl-1) inhibitor bound to drug site 3 of Human Serum Albumin.
    Zhao B; Sensintaffar J; Bian Z; Belmar J; Lee T; Olejniczak ET; Fesik SW
    Bioorg Med Chem; 2017 Jun; 25(12):3087-3092. PubMed ID: 28428041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and crystal structure of new dicopper(II) complexes having asymmetric N,N'-bis(substituted)oxamides with DNA/protein binding ability: In vitro anticancer activity and molecular docking studies.
    Zheng K; Zhu L; Li YT; Wu ZY; Yan CW
    J Photochem Photobiol B; 2015 Aug; 149():129-42. PubMed ID: 26057022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DMFC (3,5-dimethyl-
    Xiang J; Wang Z; Liu Q; Li X; Sun J; Fung KP; Liu F
    Apoptosis; 2017 Mar; 22(3):381-392. PubMed ID: 27873035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De novo design, synthesis and evaluation of benzylpiperazine derivatives as highly selective binders of Mcl-1.
    Ding X; Li Y; Lv L; Zhou M; Han L; Zhang Z; Ba Q; Li J; Wang H; Liu H; Wang R
    ChemMedChem; 2013 Dec; 8(12):1986-2014. PubMed ID: 24124106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fragment-based discovery of potent inhibitors of the anti-apoptotic MCL-1 protein.
    Petros AM; Swann SL; Song D; Swinger K; Park C; Zhang H; Wendt MD; Kunzer AR; Souers AJ; Sun C
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1484-8. PubMed ID: 24582986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel BH3 mimetic S1 potently induces Bax/Bak-dependent apoptosis by targeting both Bcl-2 and Mcl-1.
    Zhang Z; Song T; Zhang T; Gao J; Wu G; An L; Du G
    Int J Cancer; 2011 Apr; 128(7):1724-35. PubMed ID: 20503275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platinum-Based Mcl-1 Inhibitor Targeting Mitochondria Achieves Enhanced Antitumor Activity as a Single Agent or in Combination with ABT-199.
    Lu X; Wu MF; Wu JL; Zhang HQ; Liang H; Chen ZF
    J Med Chem; 2023 Jul; 66(13):8705-8716. PubMed ID: 37358241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drimane Derivatives as the First Examples of Covalent BH3 Mimetics that Target MCL-1.
    Daressy F; Malard F; Seguy L; Guérineau V; Apel C; Dumontet V; Robert A; Groo AC; Litaudon M; Bignon J; Desrat S; Malzert-Fréon A; Wiels J; Lescop E; Roussi F
    ChemMedChem; 2021 Jun; 16(11):1788-1797. PubMed ID: 33665938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MCL-1 inhibitors - where are we now (2019)?
    Fletcher S
    Expert Opin Ther Pat; 2019 Nov; 29(11):909-919. PubMed ID: 31566022
    [No Abstract]   [Full Text] [Related]  

  • 40. Norcantharidin enhances ABT-737-induced apoptosis in hepatocellular carcinoma cells by transcriptional repression of Mcl-1.
    Zhang S; Li G; Ma X; Wang Y; Liu G; Feng L; Zhao Y; Zhang G; Wu Y; Ye X; Qin B; Lu J
    Cell Signal; 2012 Sep; 24(9):1803-9. PubMed ID: 22609455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.